-
Simnova, Orna Expand Partnership to Develop BCMA-Targeted RNA Therapies
•
Shanghai Simnova Biotech Co., Ltd. (Simnova), an affiliate of Simcere Investment Group, has expanded its strategic partnership with Cambridge, Massachusetts-based Orna Therapeutics. The collaboration now includes BCMA (B-cell maturation antigen) as a designated biological target for RNA-based therapeutics development. This partnership aims to leverage Orna’s groundbreaking circular RNA (oRNA) technology…
